| Current
Clinical Pharmacology
ISSN: 1574-8847 - Volume 3, 3 Issues, 2008

Editor-in-Chief:
Jos H. Beijnen
The Netherlands Cancer Institute/Slotervaart Hospital
Amsterdam
The Netherlands
Editorial Advisory Board:
P.C. Adamson (The Children's
Hospital of Philadelphia, Philadelphia, PA, USA)
R. Agarwal (Indiana University School of
Medicine, Indianapolis, IN, USA)
R. Agbaria (Ben-Gurion University of the
Negev, Beer-Sheva, Israel)
H. Allain (University of Rennes, Rennes,
France)
K. Allegaert (University Hospital, Leuven,
Belgium)
T.M. Allen (University of Alberta, Edmonton,
Canada)
D. de Alwis (Eli Lilly & Company Ltd.,
Surrey, UK)
T. Andersson (AstraZeneca LP, Wayne, PA,
USA)
J. Ansell (Boston University School of Medicine,
Boston, MA, USA)
S. Antila (National Agency for Medicines,
Helsinki, Finland)
M. Anttila (Hormos Medical Corporation, Turku,
Finland)
V.W. Armstrong (George-August University,
Goettingen, Germany)
A. Awada (Jules Bordet Institute, Brussels,
Belgium)
M. Azizi (European Hospital Georges Pompidou,
Paris, France)
J. Azuma (Osaka University, Yamada-oka Suita,
Japan)
A. Azzi (University of Bern, Bern, Switzerland)
S.D. Baker (The Sidney Kimmel Comprehensive
Cancer Ctr., Baltimore, MD, USA)
J.P. Balthasar (The State University of New
York, Buffalo, NY, USA)
B. Bannwarth (Victor Segalen University,
Bordeaux, France)
T. Baptista (Los Andes University Medical
School, Merida, Venezuela)
J. Barnes (University of London, London,
UK)
A. Basu (City Hospital, Birmingham, UK)
J.H. Beijnen (The Netherlands Cancer Institute,
Amsterdam, The Netherlands)
R. Bellmann (Innsbruck Medical School, Innsbruck,
Austria)
S. Berg (Baylor College of Medicine, Houston,
TX, USA)
E. Bergogne-Berezin (University of Paris,
Paris, France)
M. Berkovitch (Assaf Harofeh Medical Centre,
Zerifin, Israel)
J.S. Bertino (Ordway Reseach Institute, Albany,
NY, USA)
M. Bialer (The Hebrew University of Jerusalem,
Jerusalem, Israel)
J.M. Blondeau (Royal University Hospital,
Saskatchewan, Canada)
J. Boni (Wyeth Research, Collegeville, PA,
USA)
D.W. Boulton (Bristol-Myers Squibb Pharmaceut.
Res. Inst., Princeton, NJ, USA)
F. Bressolle (University of Montpellier,
Montpellier, France)
C. Brink (North-West University, Potchefstroom,
South Africa)
M. Brown (Austin and Repatriation Medical
Centre, Victoria, Australia)
K. Budde (Charite University Hospital, Berlin,
Germany)
D.M. Burger (University Medical Center Nijmegen,
Nijmegen, The Netherlands)
J.A.L. Calbet (Univ. de Las Palmas de Gran
Canaria, Canary Islands, Spain)
M.A. Campanero (University of Navarra, Pamplona,
Spain)
D. Cattaneo (Mario Negri Institute for Pharmacological
Research, Ranica, Italy)
H.-K. Chan (University of Sydney, Sydney,
Australia)
E. Chatelut (Institut Claudius-Regaud, Toulouse,
France)
A.K. Chaturvedi (FAA Civil Aerospace Med.
Inst., Oklahoma, OK, USA)
E. Chen (Princess Margaret Hospital, Toronto,
Canada)
T. Choueiri (The Cleveland Clinic Foundation,
Cleveland, OH, USA)
B. Chowbay (National Cancer Centre, Singapore,
Singapore)
P.M. Christensen (University of Southern
Denmark, Odense C, Denmark)
S.G. Chrysant (University of Oklahoma, Oklahoma,
OK, USA)
H. Chrystyn (University of Bradford, Yorkshire,
UK)
S. Cisternino (Hospital F. Widal, Paris,
France)
T.J. Cleophas (Albert Schweitzer Hospital,
Dordrecht, The Netherlands)
S. Cox (University of Tennessee, Knoxville,
TN, USA)
S. Cremers (Novartis Pharmaceutical Corporation,
Florham Park, NJ, USA)
C.C. Crone (Inova Fairfax Hospital, Falls
Church, VA, USA)
A. Dahan (Leiden University Medical Center,
Leiden, The Netherlands)
E. Dailly (University Hospital of Nantes,
Nantes, France)
O. Dale (Norwegian University of Science
and Technology, Trondheim, Norway)
P.T. Daley-Yates (Clinical Pharmacology and
Discovery Medicine, Greenford, UK)
A.K. Daly (University of Newcastle Medical
School, Newcastle Upon Tyne, UK)
A. Dasgupta (University of Texas-Houston
Medical School, Houston, TX, USA)
E. David-Neto (University of Sao Paulo School
of Medicine, Sao Paulo, Brazil)
M. Davidson (Radiant Research, Chicago, IL,
USA)
N.M. Davies (Washington State University,
Pullman, WA, USA)
A.L. Dawidowicz (Maria Curie-Sklodowska University,
Lublin, Poland)
J.E. Dennison (Colorado State University,
Fort Collins, CO, USA)
G. Derosa (University of Pavia, Pavia, Italy)
C.L. DeVane (Medical University of South
Carolina, Charleston, SC, USA)
J. Dingemanse (Actelion Pharmaceuticals Ltd.,
Allschwil, Switzerland)
S.A. Doggrell (Auckland University of Technology,
Auckland, New Zealand)
G. Dollo (University of Rennes I, Rennes,
France)
J.G. Donnelly (New York University School
of Medicine, New York, NY, USA)
M. Dooley (Bayside Health, Victoria, Australia)
D. Drover (Stanford University, Stanford,
CA, USA)
E.F.L. Dubois (Reinier de Graaf Groep Delft-Voorburg,
Voorburg, The Netherlands)
J. Duconge (University of Turabo, Gurabo,
PR, USA)
S. Dutta (Abbott Laboratories, Abbott Park,
IL, USA)
C.B. Eap (Hospital de Cery, Prilly Lausanne,
Switzerland)
I.R. Edwards (Uppsala Monitoring Centre,
Uppsala, Sweden)
M.J. Egorin (University of Pittsburgh Cancer
Institute, Pittsburgh, PA, USA)
S.G. Kim (Seoul National University, Seoul,
Korea)
T. Kosoglou (Schering-Plough Research Institute,
Kenilworth, NJ, USA)
L. Kritharides (University of Sydney, Sydney,
Australia)
J. Kuhlmann (Bayer Health Care AG, Wuppertal,
Germany)
V. Kukongviriyapan (Khon Kaen University,
Khon Kaen, Thailand)
I.L. Kuppens (University Hospital Maastricht,
Maastricht, The Netherlands)
D.R.J. Kuypers (University of Leuven, Leuven,
Belgium)
F. Labrie (Laval University, Quebec, Canada)
V.L. Lanchote (University of Sao Paulo, Sao
Paulo, Brazil)
C.C. Lang (Ninewells Hospital and Medical
School, Dundee, UK)
K.C. Lasseter (Clinical Pharmacology Associates,
Miami, FL, USA)
F. Lavorini (University of Florence, Florence,
Italy)
C.R. Lee (University of North Carolina at
Chapel Hill, Chapel Hill, NC, USA)
M.G. Lee (Seoul National University, Seoul,
Korea)
J. de Leon (University of Kentucky, Lexington,
KY, USA)
S.-E. Leucuta (Univ. of Med. and Pharm. "Iuliu
Hatieganu", Cluj-Napoca, Romania)
Y. Leykin (Santa Maria degli Angeli Hospital,
Pordenone, Italy)
J. Lima (Nemours Children's Clinic, Jacksonville,
FL, USA)
A. LLerena (University of Extremadura, Badajoz,
Spain)
F. Locatelli (A. Manzoni Hospital, Lecco,
Italy)
W.J. Loos (Erasmus MC-Daniel den Hoed Cancer
Ctr., Rotterdam, The Netherlands)
A.W. Lyon (University of Calgary, Alberta,
Canada)
Y. Maitani (Hoshi University, Tokyo, Japan)
T. Makino (Nagoya City University, Nagoya,
Japan)
W.J. Malaisse (Brussels Free University,
Brussels, Belgium)
H. Malonne (University Libre de Bruxelles,
Bruxelles, Belgium)
C. Manach (Unite des Maladies Metab. et Micronut.,
St. Genes Champanelle, France)
A.A. Mangoni (Flinders University, Adelaide,
Australia)
J.G. Maring (Diaconessen Hospital Meppel,
Meppel, The Netherlands)
P.D. Martin (AstraZeneca, Cheshire, UK)
A. Marzo (IPAS SA, Ligornetto, Switzerland)
P.S. Masand (Duke University Medical Center,
Durham, NC, USA)
Y. Matsumura (National Cancer Center Research
Institute East, Kashiwa, Japan)
S.J. Matthews (Northeastern University, Boston,
MA, USA)
P.M.J. McSheehy (Novartis Institute for Biomedical
Research, Basel, Switzerland)
R. Mehvar (Texas Technical School of Pharmacy,
Amarillo, TX, USA)
J.J. Meier (UCLA School of Medicine, Los
Angeles, CA, USA)
M. del. Tacca (University of Pisa, Pisa,
Italy)
R. de la Torre (Institut Municipal d'Investigacio
Medica, Barcelona, Spain)
T.N. Wise (Johns Hopkins Univ. Sch. of Med.,
Falls Church, VA, USA) |